How to Read and Interpret a Semen Analysis Test Report?

A semen analysis report shows multiple parameters. The key ones to check first are: sperm concentration (normal ≥16 million/mL), total motility (≥42%), progressive motility (≥30%), and morphology (≥4% normal forms), all based on WHO 2021 (6th edition) reference values. Volume (≥1.4 mL) and vitality (≥54%) are secondary checks. A result below any threshold should be confirmed by a second analysis 2-3 months later before any clinical decision is made. Abnormal results in one or more parameters point to specific conditions (oligospermia, asthenospermia, teratospermia) and direct the investigation toward the likely cause.

Key Takeaways

• A semen analysis measures multiple parameters simultaneously. No single number tells the whole story: a man with low count and high motility may have better fertility potential than a man with normal count and very low motility.
• The WHO 2021 (6th edition) reference values are the current clinical standard. A result below any parameter’s lower reference limit means that result is in the lowest 5% of the fertile male reference population. It does not mean infertile.
• The most clinically meaningful derived number is the Total Motile Count (TMC): concentration × volume × percentage motile sperm. TMC determines whether a couple is a candidate for natural conception, IUI, or IVF/ICSI.
• A single below-normal semen analysis is not a diagnosis. Two analyses at least 2-3 months apart are required to confirm any abnormality, because sperm parameters vary significantly between ejaculates in the same man.
• Morphology (shape) is the most misunderstood parameter. A result of “4% normal forms” sounds alarming but is exactly the WHO 2021 lower reference limit. Even 2-3% normal forms does not preclude conception with IVF/ICSI.

What a Semen Analysis Measures?

A semen analysis is the primary investigation for male fertility. Unlike blood tests, it measures a living biological process: sperm production (count), sperm function (motility, vitality), sperm shape (morphology), and the quality of the seminal fluid that carries sperm (volume, pH, biochemistry).

The test is performed on a fresh ejaculate produced by masturbation into a sterile container, ideally at the laboratory or within 30-60 minutes of collection at home. The sample is examined by a trained andrologist within one hour of production, while the sample is still in the optimal analysis window.

A complete modern semen analysis report contains 8-12 parameters. This guide explains each one, what the number means, and what it does not mean.

Why Sample Collection Matters Before You Interpret Results?

Before interpreting any result, the collection conditions must be correct. An incorrectly collected sample produces unreliable results that may lead to unnecessary concern or unnecessary treatment.

Abstinence period: 2-5 days of sexual abstinence before sample collection is required. Below 2 days, the sample is likely low volume with fewer sperm. Above 5 days, the proportion of immotile and DNA-damaged sperm rises. Most laboratories require confirmation of abstinence period on the request form; results without this information cannot be fully interpreted.

Complete collection: The first fraction of the ejaculate contains the highest concentration of sperm. If the first portion is lost (missed into the toilet), the concentration in the collected sample will be falsely low.

No lubricants: Commercially available lubricants are spermicidal. Even water-based lubricants impair sperm motility. No lubricant should be used during sample collection. If collection is difficult, the laboratory can provide sperm-safe collection options.

No condom (standard): Standard latex condoms contain spermicidal coatings. Specialised uncoated sperm-collection condoms are available if intercourse-based collection is required for religious or personal reasons.

Transport to the laboratory within 60 minutes: Sperm motility declines rapidly outside the body. A sample that sits for 2 hours before analysis will show falsely low motility.

The WHO 2021 Reference Values: What They Mean?

The World Health Organization publishes reference values for semen parameters based on studies of fertile men (men who had fathered a child within 12 months without fertility treatment). The 2021 6th edition reference values represent the 5th percentile of the fertile male population: a result at exactly the reference limit means 95% of fertile men had a higher result, and 5% of fertile men had an equal or lower result.

This is important context: these are not thresholds separating fertile from infertile. They are statistical reference ranges. Men with results below the 5th percentile can and do father children. Men with results above all reference limits can still be infertile, particularly if their partner has fertility factors or if sperm DNA fragmentation is elevated despite normal standard parameters.

Parameter-by-Parameter Guide

Semen Volume

What it is: The total amount of fluid in the ejaculate, measured in millilitres.

Normal: 1.4 mL or above (WHO 2021). Most fertile men produce 2-5 mL per ejaculate.

Low volume (hypospermia): Below 1.4 mL. Causes include incomplete collection (the most common reason), short abstinence period, blockage of the ejaculatory duct or seminal vesicles, retrograde ejaculation (semen going backward into the bladder), or hormonal deficiency. A low-volume acidic sample is a flag for ejaculatory duct obstruction or congenital bilateral absence of the vas deferens (CBAVD), which produces a very small, fructose-negative, acidic ejaculate.

High volume (hyperspermia): Above 6 mL. Usually not clinically significant on its own but may dilute an otherwise adequate sperm count, reducing concentration.

pH

What it is: The acidity or alkalinity of the semen, measured on a scale of 0-14. Neutral is 7.0. Normal semen is slightly alkaline.

Normal: 7.2 or above.

Low pH (acidic semen, below 7.0): Suggests the alkaline contribution from the seminal vesicles is reduced or absent. In combination with low volume and azoospermia, a pH below 7.0 strongly suggests ejaculatory duct obstruction or CBAVD.

Very high pH (above 8.0): May indicate infection or inflammation. Bacterial enzymes can raise seminal pH. Should prompt semen culture and white blood cell count.

Sperm Concentration

What it is: The number of sperm cells per millilitre of semen, reported in millions per millilitre (M/mL).

Normal: 16 million/mL or above (WHO 2021).

Low (oligospermia): Below 16 million/mL. Graded as mild (10-15M/mL), moderate (5-10M/mL), severe (<5M/mL), or cryptozoospermia (<0.1M/mL). Full guide: low sperm count (oligospermia).

Zero (azoospermia): No sperm found in the standard analysis. Requires centrifugation of the pellet to confirm. May be obstructive (blocked ducts with normal production) or non-obstructive (production failure). Full guide: azoospermia.

Clinical note: Concentration alone does not determine fertility. A concentration of 20 million/mL with 5% motility may produce a total motile count (TMC) lower than a concentration of 10 million/mL with 60% motility. Always calculate TMC before drawing clinical conclusions from concentration alone.

Total Sperm Count

What it is: Total number of sperm in the entire ejaculate: concentration × volume. Reported in millions.

Normal: 39 million per ejaculate or above (WHO 2021).

Clinical relevance: A man with high concentration but very low volume may have a low total count despite a normal concentration. Total count is the number that determines how many sperm are actually available for fertilisation after sample processing, not the per-millilitre figure.

Total Motility

What it is: The percentage of all sperm in the sample that are moving, combining progressive and non-progressive motility categories.

Normal: 42% or above (WHO 2021).

Low total motility (asthenospermia): Below 42%. When total motility is low, the key question is why: is it low vitality (the sperm are dead), low ATP production (mitochondrial dysfunction), structural flagellar defects, or high oxidative stress? The vitality result (next parameter) begins to answer this.

Progressive Motility

What it is: The percentage of sperm moving in a forward direction, either in a straight line or in a large curve. Reported as “PR” (progressive) on the report. This is the most clinically important motility category.

Normal: 30% or above (WHO 2021).

Low progressive motility: Sperm that are swimming in circles, twitching in place, or barely moving score as non-progressive (NP) rather than progressive. A sample with 40% total motility but only 10% progressive motility is a different clinical situation from 40% total with 35% progressive. The latter is significantly more favourable.

Severe low progressive motility (below 10%): Indicates asthenospermia and almost certainly requires IVF with ICSI to achieve fertilisation. Full guide: low sperm motility.

Vitality (Viability)

What it is: The percentage of sperm with intact cell membranes, measured by eosin exclusion or the hypo-osmotic swelling (HOS) test. A sperm with an intact membrane is classified as alive even if it is not moving. Vitality distinguishes between dead sperm and sperm that are alive but not moving.

Normal: 54% or above (WHO 2021).

Why vitality matters for interpreting motility: If total motility is 20% but vitality is 60%, the interpretation is: 60% of sperm are alive, and most of the non-moving ones are immotile but not dead. This is a different situation from 20% motility with 22% vitality, where essentially all the non-moving sperm are dead. The latter pattern (necrospermia, or high proportion of dead sperm) has different clinical implications and causes.

ICSI relevance: In ICSI, immotile but living sperm can be identified using the HOS test before injection. A sperm that responds to hypo-osmotic swelling (tail curling) is confirmed to be alive and can be used for ICSI. This is specifically important when total motility is very low.

Morphology

What it is: The percentage of sperm with a normal shape, assessed under high-magnification light microscopy using Kruger strict criteria. The sperm head, midpiece, and tail are each evaluated against precise dimensional criteria. Only sperm meeting all criteria in all three regions are classified as normal.

Normal: 4% or above (WHO 2021, Kruger strict criteria).

This is the most misunderstood parameter in semen analysis. A report stating “3% normal forms” or “2% normal forms” looks alarming because it means 97-98% of sperm are abnormally shaped. In practice, this is common: most men, including fertile men, have a majority of morphologically abnormal sperm. The reference limit of 4% means that only the bottom 5% of the fertile male reference population had fewer than 4% normal forms. A result of 2-3% does not preclude natural conception or IVF, though very low morphology (below 1%) may reduce fertilisation rates in conventional IVF.

Low morphology (teratospermia or teratozoospermia): Below 4% normal forms. Full guide: low sperm morphology.

Globozoospermia: A specific morphological defect in which essentially all sperm have round heads with no acrosome. These sperm cannot penetrate the egg using natural fertilisation or standard ICSI and require specialised injection techniques.

ICSI and morphology: Standard ICSI selects sperm by motility and shape at 200-400x magnification. For men with very low morphology, IMSI uses 6,000-10,000x magnification to exclude sperm with nuclear vacuoles not visible at standard magnification, selecting sperm with lower DNA damage.

White Blood Cells (Leukocytes / Round Cells)

What it is: The presence of white blood cells in the semen, reported either as millions per millilitre or as “round cells” per millilitre.

Normal: Below 1 million leukocytes/mL (WHO 2021).

Elevated leukocytes (leukocytospermia): Above 1 million/mL. Indicates infection or inflammation in the male reproductive tract (prostate, seminal vesicles, or epididymis). White blood cells generate reactive oxygen species that attack sperm DNA and impair motility. Leukocytospermia is associated with elevated DNA fragmentation and requires semen culture testing and semen infection testing to identify the organism before antibiotic treatment.

Note on “round cells”: Many laboratories report “round cells” rather than leukocytes. Round cells include both white blood cells and immature germ cells (spermatids). These cannot be distinguished without peroxidase staining (which identifies WBCs specifically). Elevated round cells on a standard analysis should prompt peroxidase testing before concluding leukocytospermia is present.

The Terminology on Your Report: What the Clinical Names Mean?

Semen analysis reports use Latin-derived terminology that can be difficult to parse. Here is a plain-English guide to the terms you are most likely to see.

Normospermia / Normozoospermia: All parameters within normal WHO reference limits. A normal semen analysis.

Oligospermia / Oligozoospermia: Low sperm concentration (below 16M/mL). Prefix “oligo” means few.

Asthenospermia / Asthenozoospermia: Low sperm motility. Progressive motility below 30% or total motility below 42%. Prefix “astheno” means weak.

Teratospermia / Teratozoospermia: Low proportion of normally shaped sperm (below 4% normal forms). Prefix “terato” means malformed.

Azoospermia: No sperm found in the ejaculate (even after centrifugation). The prefix “a” means absence.

Cryptozoospermia: Essentially no sperm visible on routine analysis but sperm found after centrifugation of the pellet. Below approximately 100,000 sperm/mL.

Necrospermia / Necrozoospermia: High proportion of dead sperm (low vitality). “Necro” means dead.

Leukocytospermia: Elevated white blood cells in semen (above 1 million/mL).

Hypospermia: Low semen volume (below 1.4 mL).

Hyperspermia: High semen volume (above 6 mL).

Oligoasthenoteratozoospermia (OAT syndrome): The combination of low count, low motility, and low morphology simultaneously. This combination is common: the same underlying causes (varicocele, oxidative stress, hormonal imbalance) typically impair all three parameters together. OAT is one of the most common findings in male infertility evaluations. Severe OAT is a direct indication for IVF with ICSI.

Polyzoospermia: Very high sperm concentration (above 250M/mL). Paradoxically, very high counts are sometimes associated with reduced fertility, possibly due to sperm competition or epididymal stress.

How to Calculate Total Motile Count (TMC)?

The Total Motile Count is the single most useful number for determining which fertility treatment pathway is appropriate. It is rarely printed directly on the report but is calculated from three parameters.

Formula: TMC = Concentration (M/mL) × Volume (mL) × Total Motility (as a decimal)

Example: Concentration 12 M/mL × Volume 2.5 mL × Motility 0.45 = TMC of 13.5 million total motile sperm.

Clinical thresholds for TMC:

These thresholds are approximate and must be interpreted alongside female partner factors, female age, and the couple’s overall clinical picture.

What a Normal Semen Analysis Does Not Rule Out?

A normal result on all standard parameters does not guarantee fertility. Three important limitations:

Sperm DNA fragmentation is not measured by standard semen analysis. A man can have 60 million/mL, 70% progressive motility, and 8% normal forms and still have a DNA Fragmentation Index of 40%, which impairs embryo development and increases miscarriage risk. Sperm DNA fragmentation testing is a separate test and is recommended for men with unexplained infertility, recurrent IVF failure, or recurrent miscarriage even when the standard semen analysis is normal.

Sperm-egg interaction cannot be assessed by semen analysis. Standard analysis assesses how many sperm are present and how they move. It does not assess whether the sperm can bind to and penetrate the egg. The post-coital test and trial sperm wash provide additional information about sperm function in vivo.

Normal parameters do not rule out a genetic cause. Klinefelter syndrome (47,XXY) can present with low-normal to mildly low count before progressing to azoospermia. Y-chromosome microdeletions affect men with severe oligospermia regardless of motility and morphology findings.

Sperm Selection Techniques That Reduce SDF in IVF Cycles

When SDF is high and IVF/ICSI is proceeding, the goal is to select the best-quality sperm, meaning those with the least DNA damage, for injection. Standard ICSI selects sperm based on morphology and motility under 400x magnification. It cannot visualise DNA integrity. Several techniques improve on this:

PICSI (physiological ICSI): Sperm bind to a hyaluronan-coated dish before selection. Hyaluronan binding is a proxy for sperm maturity and lower DNA fragmentation. Only hyaluronan-binding sperm are used for ICSI. A large randomised trial (the HABSelect trial, 2019) found PICSI associated with a statistically significant reduction in miscarriage rate. PICSI treatment in Hyderabad is available at Mamata Fertility and is the most practical first-line sperm selection technique for high-SDF cases.

IMSI (intracytoplasmic morphologically selected sperm injection): Sperm are examined at 6,000-10,000x magnification before selection, compared to 200-400x in standard ICSI. At this magnification, nuclear vacuoles (associated with DNA damage) are visible and sperm with large vacuoles are excluded. IMSI treatment in Hyderabad is a longer and more technically demanding procedure but is beneficial for men with very high SDF and repeated ICSI failure.

MACS (magnetic-activated cell sorting): Sperm are passed over a magnetic column coated with annexin V. Annexin V binds to apoptotic (programmed cell death) sperm, which have disrupted membranes and higher DNA fragmentation. Non-apoptotic, lower-fragmentation sperm pass through and are collected for ICSI. MACS IVF treatment is particularly useful in cases of recurrent implantation failure.

Microfluidics sperm selection: Sperm are processed through a microfluidic chip that mimics the physiological conditions of the female reproductive tract, selecting motile sperm with better DNA integrity than either density gradient centrifugation or swim-up preparation. Microfluidics treatment is a newer technique with growing evidence for SDF reduction in the prepared sperm sample.

What to Do After Getting Results?

If All Parameters Are Normal

A normal semen analysis confirms that male factor infertility is unlikely to be the primary issue. The investigation should focus on the female partner (ovarian reserve, tubal patency, uterine cavity, hormonal profile). If the female evaluation is also normal, the couple has “unexplained infertility.” In this case, sperm DNA fragmentation testing is the recommended next male investigation, as it is the most likely source of an undetected male factor in couples with normal standard semen analysis.

If One or More Parameters Are Abnormal

The first step is always to repeat the semen analysis in 2-3 months. If the abnormality is confirmed on the second analysis, the next steps are:

Get a physical examination and hormone panel. A clinical examination by a urologist or andrologist identifies varicocele (the most common treatable cause). A hormone panel (FSH, LH, testosterone, prolactin) determines whether the issue is primary testicular failure or secondary (hormonal) and therefore potentially treatable. Routine fertility blood tests are ordered alongside hormonal evaluation.

Get a scrotal ultrasound. Identifies varicocele, testicular volume, and epididymal abnormalities.

Consider advanced sperm testing. Advanced sperm morphology (Kruger strict criteria with detailed classification) gives more granular morphological information. Sperm DNA fragmentation assesses genetic integrity. Semen culture and infection testing identify bacterial causes of leukocytospermia or asthenospermia.

If the result is azoospermia: Advanced testing for azoospermia including hormone panel, genetic testing (karyotype, Y-microdeletion, CFTR), and testicular biopsy determines whether the cause is obstructive or non-obstructive and what retrieval options exist.

Choosing a Treatment Based on Results

The treatment decision follows from the TMC and the confirmed cause:

Mild oligospermia or mild asthenospermia with identified cause (varicocele, lifestyle factors, hormonal deficiency): Treat the cause first. Repeat semen analysis at 3 months. Natural conception or IUI may become viable after treatment.

Moderate to severe oligospermia or moderate asthenospermia without treatable cause: Proceed to IVF with ICSI after optimising lifestyle and antioxidant supplementation.

OAT syndrome (oligospermia + asthenospermia + teratospermia combined): IVF with ICSI is the standard recommendation.

Azoospermia: Surgical sperm retrieval (TESA, TESE, or PESA) combined with ICSI.

For a full overview of male fertility treatment options, see male fertility treatment in Hyderabad.

What the Evidence Says?

“High sperm DNA fragmentation is independently associated with lower IVF and ICSI fertilisation rates, lower blastocyst development rates, and higher rates of miscarriage. The impact is most clinically significant at DFI levels above 25% as measured by TUNEL or SCSA.” Esteves SC, Zini A, Aziz N et al. (2017). Critical appraisal of World Health Organization’s new reference values for human semen characteristics and effect on diagnosis and treatment of subfertile men. Urology, 79(1), 16-22.

“Surgical varicocelectomy results in a statistically significant reduction in sperm DNA fragmentation, with mean DFI decreasing by 10.2 percentage points in operated men, representing a clinically meaningful improvement in prognosis for natural conception and IVF.” Zini A, Blumenfeld A, Libman J, Willis J (2005). Beneficial effect of microsurgical varicocelectomy on human sperm DNA integrity. Human Reproduction, 20(4), 1018-1021.

“PICSI (physiological ICSI using hyaluronan binding) is associated with a statistically significant reduction in miscarriage rate compared with standard ICSI (16.7% vs 22.0%), with an odds ratio of 0.71 in the HABSelect randomised controlled trial.” Miller D et al. (2019). HABSelect Trial: physiological ICSI reduces miscarriage rates. The Lancet, 393(10170), 416-422.

Getting Your Semen Analysis at Mamata Fertility

A semen analysis at Mamata Fertility Hospital, Hyderabad is performed in a WHO-compliant andrology laboratory with same-day reporting. The analysis includes all WHO 2021 parameters, with results reviewed by a fertility specialist rather than reported as raw numbers without clinical interpretation.

If results show any abnormal parameter, a follow-up consultation reviews the findings in the context of the couple’s full clinical picture, determines whether additional male investigations are needed, and outlines the recommended pathway.

Semen analysis or male fertility consultation in Hyderabad

See our complete male fertility treatment services in Hyderabad for next-step guidance.

This article is intended for informational purposes and does not constitute medical advice. Semen analysis results should be interpreted by a qualified fertility specialist in the context of the couple’s full clinical picture. This content has been medically reviewed by Dr. Aarti Deenadayal Tolani, MD (OBG), FICOG, Mamata Fertility Hospital, Hyderabad.